These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 10673388)
1. The lipid component of lipoproteins from Borrelia burgdorferi: structural analysis, antigenicity, and presentation via human dendritic cells. Beermann C; Lochnit G; Geyer R; Groscurth P; Filgueira L Biochem Biophys Res Commun; 2000 Jan; 267(3):897-905. PubMed ID: 10673388 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry. Bouchon B; Klein M; Bischoff R; Van Dorsselaer A; Roitsch C Anal Biochem; 1997 Mar; 246(1):52-61. PubMed ID: 9056182 [TBL] [Abstract][Full Text] [Related]
3. Lipoproteins from Borrelia burgdorferi applied in liposomes and presented by dendritic cells induce CD8(+) T-lymphocytes in vitro. Beermann C; Wunderli-Allenspach H; Groscurth P; Filgueira L Cell Immunol; 2000 May; 201(2):124-31. PubMed ID: 10831321 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. Drouin EE; Glickstein LJ; Steere AC J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399 [TBL] [Abstract][Full Text] [Related]
5. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781 [TBL] [Abstract][Full Text] [Related]
6. Human dendritic cells phagocytose and process Borrelia burgdorferi. Filgueira L; Nestlé FO; Rittig M; Joller HI; Groscurth P J Immunol; 1996 Oct; 157(7):2998-3005. PubMed ID: 8816408 [TBL] [Abstract][Full Text] [Related]
7. Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B. Sung JW; Hsieh SY; Lin CL; Leng CH; Liu SJ; Chou AH; Lai LW; Lin LH; Kwok Y; Yang CY; Chong P Vaccine; 2010 Nov; 28(51):8175-82. PubMed ID: 20937316 [TBL] [Abstract][Full Text] [Related]
8. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA. Koide S; Yang X; Huang X; Dunn JJ; Luft BJ J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380 [TBL] [Abstract][Full Text] [Related]
9. Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping. Legros V; Jolivet-Reynaud C; Battail-Poirot N; Saint-Pierre C; Forest E Protein Sci; 2000 May; 9(5):1002-10. PubMed ID: 10850810 [TBL] [Abstract][Full Text] [Related]
10. Prominent T cell response to a selectively in vivo expressed Borrelia burgdorferi outer surface protein (pG) in patients with Lyme disease. Bauer Y; Hofmann H; Jahraus O; Mytilineos J; Simon MM; Wallich R Eur J Immunol; 2001 Mar; 31(3):767-76. PubMed ID: 11241281 [TBL] [Abstract][Full Text] [Related]
11. The outer surface lipoprotein A of Borrelia burgdorferi provides direct and indirect augmenting/co-stimulatory signals for the activation of CD4+ and CD8+ T cells. Simon MM; Nerz G; Kramer MD; Hurtenbach U; Schaible UE; Wallich R Immunol Lett; 1995 Jun; 46(3):137-42. PubMed ID: 7590937 [No Abstract] [Full Text] [Related]
12. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease. Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and antigenic characterisation of Mycoplasma gallisepticum membrane proteins P52 and P67 (pMGA). Jan G; Le Hénaff M; Fontenelle C; Wróblewski H Arch Microbiol; 2001 Dec; 177(1):81-90. PubMed ID: 11797048 [TBL] [Abstract][Full Text] [Related]
14. A matrix-assisted laser desorption/ionization mass spectrometry approach to the lipid A from Mesorhizobium loti. Casabuono AC; D'Antuono A; Sato Y; Nonami H; Ugalde R; Lepek V; Erra-Balsells R; Couto AS Rapid Commun Mass Spectrom; 2006; 20(14):2175-82. PubMed ID: 16779872 [TBL] [Abstract][Full Text] [Related]
15. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170 [TBL] [Abstract][Full Text] [Related]
16. Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status. Kalish RS; Wood JA; Golde W; Bernard R; Davis LE; Grimson RC; Coyle PK; Luft BJ J Infect Dis; 2003 Jan; 187(1):102-8. PubMed ID: 12508152 [TBL] [Abstract][Full Text] [Related]
17. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Lee JS; Lee JC; Lee CM; Jung ID; Jeong YI; Seong EY; Chung HY; Park YM Biochem Pharmacol; 2007 Jun; 74(1):86-97. PubMed ID: 17482145 [TBL] [Abstract][Full Text] [Related]
18. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917 [TBL] [Abstract][Full Text] [Related]
19. T cell activation by lipopeptide antigens. Moody DB; Young DC; Cheng TY; Rosat JP; Roura-Mir C; O'Connor PB; Zajonc DM; Walz A; Miller MJ; Levery SB; Wilson IA; Costello CE; Brenner MB Science; 2004 Jan; 303(5657):527-31. PubMed ID: 14739458 [TBL] [Abstract][Full Text] [Related]